The clinical significance of the circumferential resection margin following preoperative pelvic chemo-radiotherapy in rectal cancer: why we need a common language-Reference-Cited by-同舟云学术

The clinical significance of the circumferential resection margin following preoperative pelvic chemo-radiotherapy in rectal cancer: why we need a common language

Published:2006-11 Issue:9 Volume:8 Page:800-807
ISSN:1462-8910
Container-title:Colorectal Disease
language:en
Short-container-title:Colorect Dis

Author:

Glynne-Jones R.,Mawdsley S.,Novell J. R.

Publisher

Wiley

Subject

Gastroenterology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1463-1318.2006.01139.x/fullpdf

Reference54 articles.

1. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial

2. LOCAL RECURRENCE OF RECTAL ADENOCARCINOMA DUE TO INADEQUATE SURGICAL RESECTION

3. Extent of mesorectal spread and involvement of lateral resection margin as prognostic factors after surgery for rectal cancer

4. Mesorectal spread and micrometastasis of rectal cancer studied with large slice technique and tissue microarray

5. Combined pulmonary tumour embolectomy and extended right hepatectomy with inferior vena cava resection for advanced hepatocellular carcinoma

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current update on the role of endoanal ultrasound: a primer for radiologists;Abdominal Radiology;2024-04-05

2. Localized Rectal Cancer: Indian Consensus and Guidelines;Indian Journal of Medical and Paediatric Oncology;2024-02-09

3. The definition of clear resection margins in locally recurrent rectal cancer—time for consensus;British Journal of Surgery;2024-01

4. Variations in the definition and perceived importance of positive resection margins in patients with colorectal cancer – an EYSAC international survey;European Journal of Surgical Oncology;2023-11

5. Neoadjuvant chemotherapy with modified FOLFOXIRI for locally advanced rectal cancer to transform effectively EMVI and MRF from positive to negative: results of a long-term single center phase 2 clinical trial;BMC Cancer;2023-06-27